Valuation: Hugel, Inc.

Market Cap 2,506B 1.86B 1.61B 1.52B 1.38B 2.59B 178B 2.61B 18.17B 7B 90.47B 6.99B 6.83B 288B P/E 2026 *
16.4x
P/E 2027 * 12.9x
Enterprise Value 1.95B 1.45M 1.25M 1.18M 1.07M 2.01M 139M 2.03M 14.13M 5.45M 70.37M 5.44M 5.32M 224M EV / Sales 2026 *
3.69x
EV / Sales 2027 * 2.81x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day+0.43%
1 week-4.53%
Current month-7.94%
1 month-9.38%
3 months-5.11%
6 months-3.13%
Current year+0.65%
1 week 225,500
Extreme 225500
238,500
1 month 225,500
Extreme 225500
262,000
Current year 216,500
Extreme 216500
308,500
1 year 208,500
Extreme 208500
325,000
3 years 119,000
Extreme 119000
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 28/04/2022
Director/Board Member 56 28/04/2022
Director/Board Member 51 28/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/25 Exercice 1,200 0.0095%
20/05/25 Sell 1,200 0.0095%
19/05/25 Exercice

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-4.53%-27.61%+84.13% 1.86B
+1.57%-4.11%+41.74%-4.64% 79.26B
+1.89%+0.78%+523.95%+30.03% 58.56B
+0.96%-0.93%-15.31%-35.30% 58.62B
+0.35%-3.14%-11.03%+26.34% 48.75B
+2.38%+0.10%+1.49%+155.34% 46.32B
+0.10%-1.57%+50.05%-15.20% 32.12B
+0.59%-3.60%+47.04%+92.49% 24.77B
-0.46%-3.79%+0.84%+145.92% 21.5B
+2.24%-0.40%+66.12%+100.09% 15.97B
Average +0.81%-2.88%+67.73%+57.92% 38.77B
Weighted average by Cap. +0.90%-2.53%+93.94%+37.39%

Financials

2026 *2027 *
Net sales 528B 392M 340M 320M 291M 545M 37.55B 549M 3.83B 1.47B 19.05B 1.47B 1.44B 60.57B 641B 476M 412M 389M 353M 662M 45.61B 667M 4.65B 1.79B 23.14B 1.79B 1.75B 73.56B
Net income 171B 127M 110M 104M 94.38M 177M 12.19B 178M 1.24B 479M 6.19B 478M 467M 19.67B 221B 164M 142M 134M 121M 228M 15.7B 230M 1.6B 616M 7.96B 615M 602M 25.32B
Net Debt -557B -414M -358M -338M -307M -576M -39.64B -580M -4.04B -1.56B -20.11B -1.55B -1.52B -63.93B -705B -523M -454M -428M -388M -728M -50.17B -734M -5.11B -1.97B -25.45B -1.97B -1.92B -80.91B
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
620
Date Price Change Volume
14/09/26 ₩232,000.00 +0.43% 31,158
11/09/26 ₩231,000.00 -2.12% 32,932
10/09/26 ₩236,000.00 0.00% 41,740
09/09/26 ₩236,000.00 -0.84% 24,658
08/09/26 ₩238,000.00 -2.06% 22,715
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
232,000.00KRW
Average target price
369,312.50KRW
Spread / Average Target
+59.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!